# Levosimendan for Veno-arterial ECMO Weaning

> **NCT04323709** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 200 (actual)

## Conditions studied

- Cardiogenic Shock
- Refractory Shock

## Interventions

- **OTHER:** Data collection
- **OTHER:** Data analysis

## Key facts

- **NCT ID:** NCT04323709
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-01-31
- **Final completion:** 2020-03-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04323709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04323709, "Levosimendan for Veno-arterial ECMO Weaning". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04323709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*